Cellotex

📍 Tel Aviv, Malta🗓 Founded 2022👥 15 employees💰 Last funded Aug 2021
Alternative Medicine🌐 Cellotex.com
Website LinkedIn
Cellotex is revolutionizing the approach to patient care through precise medication. Traditional methods often miss the mark and are unable to adapt quickly to individual needs. Were changing that. Our digital solution provides personalized prescriptions and regimens, tracks medication effectiveness in real time, and provides essential data and insights to doctors for custom medication. With existing sales in Germany, we focus on cannabinoid medication, working closely with compounding pharmacies and clinics. As we enter our seed funding round, we see a strong interest from stakeholders in the healthcare sector. With existing sales in Germany, we focus on cannabinoid medication, working closely with compounding pharmacies and clinics. As we enter our seed funding round, we see a strong interest from stakeholders in the healthcare sector.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
1
Frequently asked questions
Who invested in Cellotex?
Cellotex has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Cellotex last raise funding?
The most recent investment in Cellotex recorded on gritt.io was in August 2021.
When was Cellotex founded?
Cellotex was founded in 2022.
What industry is Cellotex in?
Cellotex operates in Alternative Medicine. Find similar Alternative Medicine investors on gritt.io.
Where is Cellotex based?
Cellotex is headquartered in Tel Aviv, Malta.